Journal
BJU INTERNATIONAL
Volume 104, Issue 7, Pages 960-967Publisher
WILEY
DOI: 10.1111/j.1464-410X.2009.08545.x
Keywords
overactive bladder; flexible dosing; antimuscarinic
Categories
Funding
- Astellas Pharma Europe Ltd
Ask authors/readers for more resources
Several studies with modern antimuscarinics have used a flexible-dosing strategy. We reviewed data from several studies with solifenacin, darifenacin and oxybutynin extended-release that evaluated the impact of dose flexibility on clinical management. A strategy based on patient-requested dose increases was found to be consistently effective in improving the symptoms of overactive bladder. Patients requesting a dose increase often had more severe symptoms at baseline than those who did not request a dose increase, and these patients derived most benefit from the increased dose. Specialists and family doctors should encourage open discussion with their patients about requesting dose titration so as to meet patients' individual needs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available